Advancing Cell Therapies for Solid Tumors
MD Anderson and Refuge Biotechnologies announced a strategic
collaboration to advance new cell therapies for potential treatment of
solid tumors. The agreement pairs Refuge’s innovative technologies
with the experience and industrial capability of the Biologics
Development platform.